Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 696 of 6351
-
Can breast cancer drugs tackle a childhood brain tumor?
Knowledge-focused Recruiting nowMedulloblastoma (MB), a rare yet critical pediatric brain tumor, is divided into 4 molecular subgroups (WNT, SHH, Group 3, Group 4), each with distinct genetic profiles. Despite diagnostic and therapeutic advances, neurotoxicity from standard treatments (resection, radiotherapy, …
Early phase 1 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New mRNA HIV vaccine trial aims to train immune system to fight virus
Vaccine OngoingThis is a multicenter, open-label, non-randomized, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of CH505M5 N197D mRNA-gp160 and CH505 TF mRNA-gp160. Both products are mRNA encapsulated in lipid nanoparticles (LNPs) (subsequently referred t…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
New drug combo aims to save kidneys in rare bladder cancer
Disease control Recruiting nowThis trial will evaluate the use of combination pembrolizumab and enfortumab vedotin for patients with high grade non-metastatic (cN0/NxMx, no measurable regional lymph nodes, no metastases) upper tract urothelial cancer (UTUC), preferring to forego standard of care radical nephr…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
AI vs. radiologists: 150,000 women in landmark breast cancer screening trial
Knowledge-focused Recruiting nowThe purpose of this randomized controlled trial is to compare the number of breast cancers detected among women who had their screening mammograms interpreted by artificial intelligence (AI) in combination with one or two breast radiologists to the number of breast cancers detect…
Sponsor: Norwegian Institute of Public Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Could a Lower-Dose RSV vaccine protect babies just as well?
Vaccine Stopped earlyThis study was a Phase III, parallel group, randomized, observer blind, placebo controlled, multi-national, multi-center, multi-arm study conducted in 42 healthy children enrolled at 6 months to \<22 months of age. The purpose of the study was to evaluate the non-inferiority of t…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Vaccine
Last updated Aug 05, 2026 00:00 UTC
-
Immunotherapy drug nivolumab takes on rare childhood cancer
Disease control Recruiting nowInvestigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
Phase 2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
One-of-a-Kind ALS drug shows promise in first human test
Disease control CompletedThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with amyotrophic lateral sclerosis (ALS) due to a pathogenic variant in TARDBP.
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Checkerboard patterns may train young brains to see better
Symptom relief Recruiting nowRestorative visual rehabilitation is frequently used to enhance the visual development and function of children with low vision. An important strategy within this field is visual stimulation, which is particularly used for infants and toddlers with low vision, as well as for chil…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a simple ultrasound replace CT scans for Kids' head injuries?
Diagnosis Recruiting nowTo improve patient selection for head CT, a safe and high sensitivity screening neuroimaging modality is needed. Currently many clinicians must make treatment decisions based solely on the patients clinical exam, which has low sensitivity and specificity and low inter-rater relia…
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
New drug combo aims to tame stubborn high blood pressure
Disease control CompletedThe main objective of the study will be to assess the efficacy and safety of Sacubitril/Allisartan (240mg) and Amlodipine (5mg) in patients with essential hypertension uncontrolled after 4-week treatment with Sacubitril/Allisartan (240mg).
Phase 3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could smart alerts end the 'Diagnostic Overshadowing' that endangers disabled patients?
Knowledge-focused Recruiting nowThe goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholder…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
New pill takes aim at Hard-to-Treat KRAS cancers
Disease control Recruiting nowThis is a multicenter, open-label, phase I/IIa to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of pan-KRAS inhibitor JAB-23E73 in patients with advanced solid tumors harboring KRAS mutations or amplification. The s…
Phase 1/2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Frozen testicle tissue may help men become dads after childhood cancer
Disease control Recruiting nowFreezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells in case of imminent gonadotoxic treatment during childhood. In case of total azoospermia or absence of spermatozoa that can be used for intra-cytoplasmic injection (ICSI) in adulth…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New targeted therapy aims to extend life in stomach cancer
Disease control Recruiting nowThe study evaluated the overall survival (OS) of SHR-A1904 versus investigator-selected treatment in second-line CLDN18.2-positive advanced GC/GEJC patients
Phase 3 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a Breathing-Synchronized pacemaker boost heart function after bypass?
Disease control CompletedThe goal of this clinical trial is to test a new type of pacemaker in heart failure patients following a heart bypass operation. The new pacemaker restores respiratory sinus arrhythmia which is a natural pattern where the heart rate increases when the participants breathe in and …
Sponsor: Ceryx Medical Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug combo shows promise in shrinking stomach tumors before surgery
Disease control OngoingThis study is a multicenter, randomized, uncontrolled clinical trial to evaluate the efficacy and safety of camrelizumab combined with or without apatinib and SOX of neoadjuvant treatment for resectable locally advanced gastric or gastroesophageal junction adenocarcinoma.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New lupus drug shows promise in major trial
Disease control Recruiting nowThe purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Trikafta's long-term safety tested in toddlers with cystic fibrosis
Disease control OngoingThe purpose of the study is to evaluate the long-term safety, tolerability, efficacy, and pharmacodynamics (PD) of elexacaftor (ELX)/tezacaftor (TEZ)/ivacaftor (IVA).
Phase 3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New asthma drug aims to slash severe attacks in eosinophilic patients
Disease control OngoingThe purpose of this study is to evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients with Eosinophil Phenotype
Phase 3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New trial tests best timing for sepsis drug to save lives and kidneys
Disease control Recruiting nowThe norepinephrine and vasopressin for rescue versus early vasopressin for vasopressor dependent sepsis (NoVa) is a phase 3, multicenter, open-label, randomized controlled trial comparing an early vasopressin initiation strategy versus norepinephrine plus vasopressin initiation o…
Phase 3 • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC